Focal Epilepsy
Neurological
Focal Epilepsy is treated with 17 medications in our database, including Gabapentin, Lacosamide, GABAPENTIN, brivaracetam, Eslicarbazepine Acetate, and 12 more. 8 of these have manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Pfizer, UCB, Sunovion, AbbVie, Novartis and others. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Focal Epilepsy treatment below.
What help exists for Focal Epilepsy
13
drugs indexed
9
with copay cards
9
with patient assistance
0
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Focal Epilepsy
13 totalZONISADE
ZONISAMIDE
ππNeurontin
gabapentin Β· Pfizer
ππVALPROIC ACID
Valproic Acid Β· AbbVie
Eprontia
Topiramate
ππEslicarbazepine Acetate
eslicarbazepine acetate Β· Sunovion
GABAPENTIN
gabapentin Β· Pfizer
ππLACOSAMIDE
lacosamide Β· UCB
Oxcarbazepine
oxcarbazepine
ππBRIVARACETAM
brivaracetam Β· UCB
ππCarbamazepine
Carbamazepine
ππZonegran
Zonisamide Β· Advanz
Vimpat
lacosamide Β· UCB
ππCarbatrol
carbamazepine Β· Takeda
ππ
π = copay card Β· π = patient assistance program
Prior authorization patterns for Focal Epilepsy drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
Showing 10 of 25 PA rules for Focal Epilepsy drugs. View individual drug pages for complete PA detail.